Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 177.740
- -0.210-0.12%
Trading May 5 15:43 ET
19.84BMarket Cap22.47P/E (TTM)
179.277High176.865Low572.68KVolume177.845Open177.950Pre Close102.07MTurnover0.52%Turnover Ratio23.11P/E (Static)111.64MShares179.32052wk High2.86P/B19.75BFloat Cap132.77952wk Low3.80Dividend TTM111.10MShs Float179.320Historical High2.14%Div YieldTTM1.36%Amplitude2.559Historical Low178.231Avg Price1Lot Size
Quest Diagnostics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 103.90%314M | 4.87%1.33B | -11.95%464M | 71.98%356M | -18.92%360M | 63.83%154M | -25.96%1.27B | 57.78%527M | -58.76%207M | 10.45%444M |
| Net income from continuing operations | 12.98%235M | 1.43%921M | 15.12%236M | 0.00%237M | -3.61%240M | -4.15%208M | -10.54%908M | 76.72%205M | -14.13%237M | -0.40%249M |
| Depreciation and amortization | 20.69%140M | 12.30%493M | 23.85%135M | 12.61%125M | 4.46%117M | 8.41%116M | 0.46%439M | -6.03%109M | 2.78%111M | 4.67%112M |
| Deferred tax | 138.89%7M | 126.53%13M | 440.00%34M | 165.22%15M | -50.00%-18M | -350.00%-18M | -5,000.00%-49M | 77.27%-10M | -135.38%-23M | -152.17%-12M |
| Other non cash items | -109.09%-1M | -63.41%15M | -106.90%-2M | -90.91%1M | 350.00%5M | 266.67%11M | -37.88%41M | 0.00%29M | 175.00%11M | -106.90%-2M |
| Change In working capital | 51.61%-90M | -38.62%-201M | -81.03%33M | 71.62%-42M | -107.41%-6M | 26.19%-186M | -221.85%-145M | 87.10%174M | -577.42%-148M | 400.00%81M |
| -Change in receivables | 11.40%-101M | -373.33%-71M | -2.82%69M | 43.75%-27M | -95.00%1M | -96.55%-114M | -106.10%-15M | -15.48%71M | -500.00%-48M | -74.36%20M |
| -Change in payables and accrued expense | 65.45%-38M | 10.53%-51M | -88.51%20M | 125.00%20M | -61.22%19M | 45.00%-110M | 68.33%-57M | 1,840.00%174M | -328.57%-80M | 136.30%49M |
| -Change in other working capital | 28.95%49M | -8.22%-79M | 21.13%-56M | -75.00%-35M | -316.67%-26M | 533.33%38M | -237.74%-73M | -473.68%-71M | -25.00%-20M | -60.00%12M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 103.90%314M | 4.87%1.33B | -11.95%464M | 71.98%356M | -18.92%360M | 63.83%154M | -25.96%1.27B | 57.78%527M | -58.76%207M | 10.45%444M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 46.01%-115M | -140.15%-2.55B | -340.35%-502M | -1,426.17%-1.63B | 70.67%-200M | -34.81%-213M | -95.40%-1.06B | 34.48%-114M | 9.32%-107M | -731.71%-682M |
| Capital expenditure reported | -12.50%-117M | -4.17%-425M | -70.83%-123M | -0.95%-106M | 11.54%-92M | 18.11%-104M | -0.99%-408M | 51.02%-72M | 11.02%-105M | -36.84%-104M |
| Net business purchase and sale | --0 | -254.17%-2.16B | ---383M | -76,550.00%-1.53B | 81.66%-106M | -358.06%-142M | -324.31%-611M | --0 | ---2M | -57,700.00%-578M |
| Net other investing changes | -93.94%2M | 197.62%41M | --4M | --6M | ---2M | --33M | -940.00%-42M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 46.01%-115M | -140.15%-2.55B | -340.35%-502M | -1,426.17%-1.63B | 70.67%-200M | -34.81%-213M | -95.40%-1.06B | 34.48%-114M | 9.32%-107M | -731.71%-682M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -266.67%-561M | 577.50%1.08B | -230.77%-170M | 2,232.53%1.77B | -292.06%-363M | -101.32%-153M | 109.24%160M | 123.85%130M | 82.49%-83M | 178.10%189M |
| Net issuance payments of debt | ---385M | 106.28%1.54B | -100.21%-1M | 4,492.86%1.85B | -194.36%-301M | --0 | 37,500.00%748M | 47,200.00%471M | ---42M | --319M |
| Net common stock issuance | ---- | 45.09%-151M | ---- | ---- | ---- | ---- | 80.47%-275M | ---- | ---- | ---- |
| Cash dividends paid | -6.33%-84M | -5.41%-331M | -5.00%-84M | -5.00%-84M | -5.00%-84M | -6.76%-79M | -2.95%-314M | -6.67%-80M | -2.56%-80M | -2.56%-80M |
| Proceeds from stock option exercised by employees | 141.67%29M | 1.39%73M | 75.00%21M | 84.62%24M | -27.27%16M | -52.00%12M | -41.46%72M | -55.56%12M | -53.57%13M | -62.07%22M |
| Net other financing activities | -40.70%-121M | 29.58%-50M | 2,150.00%45M | -157.69%-15M | 108.33%6M | -218.52%-86M | 49.29%-71M | 105.71%2M | 152.00%26M | -227.27%-72M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -266.67%-561M | 577.50%1.08B | -230.77%-170M | 2,232.53%1.77B | -292.06%-363M | -101.32%-153M | 109.24%160M | 123.85%130M | 82.49%-83M | 178.10%189M |
| Net cash flow | ||||||||||
| Beginning cash position | -19.97%549M | 117.78%686M | 434.27%764M | 115.08%271M | 170.86%474M | 117.78%686M | -63.88%315M | -79.57%143M | -84.05%126M | -75.42%175M |
| Current changes in cash | -70.75%-362M | -135.04%-130M | -138.31%-208M | 2,800.00%493M | -314.29%-203M | -51.43%-212M | 166.61%371M | 241.04%543M | 118.89%17M | -162.82%-49M |
| Effect of exchange rate changes | --1M | ---7M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| End cash Position | -60.34%188M | -19.97%549M | -19.97%549M | 434.27%764M | 115.08%271M | 170.86%474M | 117.78%686M | 117.78%686M | -79.57%143M | -84.05%126M |
| Free cash flow | 294.00%197M | 5.21%909M | -25.05%341M | 145.10%250M | -21.18%268M | 251.52%50M | -34.25%864M | 143.32%455M | -73.44%102M | 4.29%340M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
